Health Bulletin 30/November/2021

Here are top Health stories of the day

Court junks plea of 2 Accused in PGIMER MD seat scam, finds Prima Facie Case against 27

In the latest development regarding the MD seat scam of the Post Graduate Institute of Medical Education and Research (PGIMER), the Special Judicial Magistrate, CBI, Chandigarh, Inderjeet Singh has recently rejected the discharge applications of two accused allegedly involved in the case.

Further, while considering the merits of the case, the court has found a prima facie case against all the 27 people who were accused of their alleged involvement in the nine-year-old scam, reports Tribune India.

For more details, check out the full story on the link below:

Court Junks Plea Of 2 Accused In PGIMER MD Seat Scam, Finds Prima Facie Case Against 27

AIIMS on the lookout for new Director, releases advertisement, Details

The All India Institute of Medical Sciences (AIIMS), Delhi has recently issued an advertisement inviting applications for the post of Director, as the present Director Dr Randeep Guleria will retire in March next year after a 30-year long inning at the premier institute.

Dr Guleria was appointed as the director in 2017, at the time he was heading AIIMS' department of pulmonary medicine. However, with his tenure nearing completion in March, the process of selection of a new director for AIIMS has begun.

For more details, check out the full story on the link below:

AIIMS On The Lookout For New Director, Releases Advertisement, Details

NEET PG Counselling delay: Here is how doctors reacted Pan India

As there is no solution regarding the pending NEET-PG Counseling yet, doctors all across India are still continuing strikes in their respective states demanding immediate interference of the Government in the issue.

Although the Union Health Minister Shri Mansukh Mandaviya recently met doctors' association including the Federation of Resident Doctors' Association (FORDA) and Indian Medical Association Junior Doctors' Network (IMA-JDN), and assured them that the issue would be sorted soon, any solution regarding the pending counseling process for PG medical admission is yet to arrive.

For more details, check out the full story on the link below:

NEET PG Counselling Delay: Here Is How Doctors Reacted Pan India

Dr V Mohan bags recognition as Tamil Nadu's topmost scientist

Eminent Indian Diabetologist Dr V Mohan, President, Madras Diabetes Research Foundation (MDRF) and Chairman, Dr Mohan's Diabetes Specialities Centre, has been ranked and recognised as Tamil Nadu's topmost scientist-cum-researcher in a list compiled and published by Stanford University, Elsevier BV and SciTech Strategies.

A team from Stanford University along with Elsevier BV released an updated list of the Top 2% of scientists worldwide, including the citations of the scientists in 2020. Over 100 scientists from Tamil Nadu were included in the list of Top 2% of scientists.

For more details, check out the full story on the link below:

Eminent Diabetologist Dr V Mohan Recognized As Tamil Nadu's Topmost Scientist

AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study

In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) to conduct a Phase 3 clinical trial of oncology drug Trastuzumab Deruxtecan, which is an antibody used to treat certain types of unresectable or metastatic HER-2 positive breast cancer.

This comes in the wake of the Phase III clinical trial protocol presented by AstraZeneca at the recent SEC meeting for Oncology and Haematology.

For more details, check out the full story on the link below:

AstraZeneca Gets CDSCO Panel Nod To Conduct Cancer Drug Trastuzumab Deruxtecan Study